These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37097147)

  • 21. Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    McCormick AA; Shakeel A; Yi C; Kaur H; Mansour AM; Bakshi CS
    PLoS One; 2018; 13(4):e0194614. PubMed ID: 29684046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An
    Golovliov I; Lindgren H; Eneslätt K; Conlan W; Mosnier A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
    [No Abstract]   [Full Text] [Related]  

  • 23. The D-alanyl-d-alanine carboxypeptidase enzyme is essential for virulence in the Schu S4 strain of Francisella tularensis and a dacD mutant is able to provide protection against a pneumonic challenge.
    Kijek TM; Mou S; Bachert BA; Kuehl KA; Williams JA; Daye SP; Worsham PL; Bozue JA
    Microb Pathog; 2019 Dec; 137():103742. PubMed ID: 31513897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence.
    Russo BC; Horzempa J; O'Dee DM; Schmitt DM; Brown MJ; Carlson PE; Xavier RJ; Nau GJ
    Infect Immun; 2011 Sep; 79(9):3665-76. PubMed ID: 21670171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.
    Reed DS; Smith LP; Cole KS; Santiago AE; Mann BJ; Barry EM
    Infect Immun; 2014 May; 82(5):2098-105. PubMed ID: 24614653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.
    Alqahtani M; Ma Z; Fantone K; Malik M; Bakshi CS
    Infect Immun; 2021 Jun; 89(7):e0013421. PubMed ID: 33875472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Schu S4
    Cunningham AL; Mann BJ; Qin A; Santiago AE; Grassel C; Lipsky M; Vogel SN; Barry EM
    Virulence; 2020 Dec; 11(1):283-294. PubMed ID: 32241221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative review of Francisella tularensis and Francisella novicida.
    Kingry LC; Petersen JM
    Front Cell Infect Microbiol; 2014; 4():35. PubMed ID: 24660164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanylate-Binding Proteins Are Critical for Effective Control of
    Mohammadi N; Lindgren H; Golovliov I; Eneslätt K; Yamamoto M; Martin A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2020; 10():594063. PubMed ID: 33363054
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
    Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
    Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal models of Francisella tularensis infection.
    Rick Lyons C; Wu TH
    Ann N Y Acad Sci; 2007 Jun; 1105():238-65. PubMed ID: 17395735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.
    Chance T; Chua J; Toothman RG; Ladner JT; Nuss JE; Raymond JL; Biot FV; Demons S; Miller L; Halasohoris S; Mou S; Koroleva G; Lovett S; Palacios G; Vietri NJ; Worsham PL; Cote CK; Kijek TM; Bozue JA
    PLoS One; 2017; 12(3):e0174106. PubMed ID: 28328947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.
    Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
    PLoS One; 2010 Oct; 5(10):e13349. PubMed ID: 20967278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
    Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J
    Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.
    Stinson E; Smith LP; Cole KS; Barry EM; Reed DS
    Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27511964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophages Demonstrate Guanylate-Binding Protein-Dependent and Bacterial Strain-Dependent Responses to
    Mohammadi N; Lindgren H; Yamamoto M; Martin A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2021; 11():784101. PubMed ID: 35004352
    [No Abstract]   [Full Text] [Related]  

  • 39. An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia.
    Marshall LE; Nelson M; Davies CH; Whelan AO; Jenner DC; Moule MG; Denman C; Cuccui J; Atkins TP; Wren BW; Prior JL
    J Immunol Res; 2018; 2018():8087916. PubMed ID: 30622981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains.
    Wu TH; Zsemlye JL; Statom GL; Hutt JA; Schrader RM; Scrymgeour AA; Lyons CR
    Vaccine; 2009 Jul; 27(34):4684-93. PubMed ID: 19520198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.